Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.13%) to 8926.55, DAX (0.21%) to 24009.38, CAC40 (0.57%) to 7722.09, STOXX 600 (0.57%) to 541.84

Jul 16 ,2025

  • Synopsis:

    • European equity markets finished lower extending losses into the close. Telecom, Financials and Insurance the best performers. Tech, Autos, Construction & Metals, and Chemicals the biggest laggards. US equities also lower in midday trading. Treasuries mixed with curve bull steepening; 30-year bond weaker, now at 5.05%. Dollar index down 0.2%. Gold up 0.6%. Bitcoin futures up 2.7%, off best levels. WTI crude off 1.2%.

    • Several moving pieces with attention on Fed headlines amidst claims from White House official that Trump to fire Fed Chair Powell soon. Headline has weighed heavily on the dollar. In latest tariff rhetoric, US Treasury Secretary Bessent downplayed the urgency of the US-China tariff truce expiry of 12-Aug noting the deadline was flexible and talks were going well. Confirmation still pending with still no formal statement released on the Vietnam deal. BoE's Bailey cautioned that tariffs may fragment world economy reducing activity. EU member states reportedly closer to deploying anti-coercion instrument if Trump applies 30% tariffs.

    • Early focus in Europe was on UK inflation data, which came in above consensus. Headline at 3.6% versus 3.4% expected and core at 3.7% versus 3.6% expected. European earnings outlook worsened following latest Trump tariff threats. French far-right leader Le Pen vowed to bring down PM Bayrou's government unless he reverses recent budget plan. In the UK, British finance minister Reeves pledged to ease regulation further and announced measures to boost finance sector. Today, difficult negotiations on EU's next seven-year budget begin in earnest. German Bundesbank sees economy stagnating in Q2.

    • On the earnings front, ASML Holding (ASML.NA) Q2 orders surged to €5.5B, driven by AI chip demand, but said may not achieve growth in 2026. Skandinaviska Enskilda Banken (SEB.A.SS) beat profit forecasts despite lower interest rates. Rio Tinto (RIO.LN) iron ore shipments dip, eyes Pilbara expansion. Renault (RNO.FP) delivers H1 revenue a touch ahead of consensus, however cuts FY profit forecast amid market slump. Richemont (CFR.SW) reported beat on Q1 jewelry sales.

    • In other corporate news, AE Systems (BA.LN) eyes new Eurofighter Typhoon orders from export markets. Daimler Truck (DTG.GR) to lay off 2,000 workers amid weak US, Mexico demand. Diageo (DGE.LN) announces that Debra Crew has stepped down as CEO with immediate effect, by mutual agreement. DNO (DNO.NO) temporarily suspends production at Kurdistan fields following explosions with Genel Energy (GENL.LN) shares coming under pressure as a result and Gulf Keystone Petroleum (GKP.LN) also temporarily suspending production at its Shaikan Field operations due to the explosions in the vicinity.

    • In M&A headlines, Stellantis (STLAM.IM) to discontinue its hydrogen fuel cell technology JV Symbio and has initiated discussions with the shareholders Faurecia (FRVIA.FP) and Michelin (MC.FP). BPER Banca (BPE.IM) announces final result of offer to acquire Banca Popolare di Sondrio (BPSO.IM) confirms provisional results. Media reports Nippon (5401.JP) and Mitsui (8031.JP) expected to assist Peabody Energy (BTU) in acquiring Anglo American's (AAL.LN) Queensland coal mines. Further in market rumors, shares of Essentra (ESNT.LN) moved higher midday on renewed takeover speculation, but have since reversed. Handelsblatt reports Rheinmetall (RHM.GR) is exploring sale of auto division 'Power Systems', in discussions with One Equity Partners as potential buyer.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Insurance +0.52%, Financial Svcs +0.40%, Telecom +0.23%, Persnl & HHold Goods +0.15%, Media +0.03%, Utilities +0.02%, Health Care (0.07%), Basic Resources (0.16%), Food & Beverage (0.23%), Banks (0.27%), Travel & Leisure (0.31%), Retail (0.34%)

      • Underperformers:

        • Technology (2.18%), Autos & Parts (1.81%), Construct & Mtls (1.39%), Chemicals (1.34%), Oil & Gas (0.82%), Ind Goods & Svcs (0.68%), Real Estate (0.61%)

    • Macro:

      • Geopolitics:

        • EU's Kallas welcomes Trump's Patriot missile plan, urges US burden-sharing: Politico

        • EU proposes safeguards to win France's support for Mercosur trade deal: FT

        • Europe's charm offensive, weapons deal helped turn Trump against Putin on Ukraine: link and Politico

      • UK:

        • UK inflation unexpectedly rises to highest level since January, driven by food prices (Bloomberg, FT)

        • UK finance minister pledges deregulation, seeks to boost finance sector and economic growth (Reuters, FT)

      • France:

        • Marine Le Pen threatens to topple French government over budget cuts: Politico

        • French finance minister seeks support for 2026 budget, open to talks with opposition: Bloomberg

        • Bank of France Recommends Cutting Regulated Savings Rate to 1.7% (Bloomberg )

      • Germany:

        • Germany strikes deal with EU for flexible fiscal plan to boost investment: Politico

      • Politics:

        • EU Commission proposes €1.717 trillion budget for 2028-2034 amid tense talks: Politico

        • EU's von der Leyen says new budget fit for 'new era (Reuters )

      • Trade & Tariffs:

        • EU trade chief heads to Washington in search of tariffs solution (Reuters )

        • European Union member states grappling with President Trump's 30% tariff threat (NYTimes)

      • Central Banks:

        • ECB's Nagel calls for "steady hand" amid Trump's tariff threat, complicating EU decision-making: Yahoo Finance

        • BoE's Bailey warns of harm to households worldwide from US trade wars, urges cooperation (Bloomberg, Reuters)

    • Peripheral markets:

      • Italy:

        • Going too far past 10% on tariffs is unsustainable says Economy Minister Giancarlo Giorgetti (ANSA)

        • Foreign Minister Tajani, US Secretary of State Rubio held positive talks focusing on tariffs, Ukraine, and Middle East (ANSA )

      • Switzerland:

        • Swiss Trade Deal With US Is Awaiting Trump's Sign Off, Bern Says (Bloomberg )

      • Spain:

        • Housing Supply Plunges 20% During Quarter as Prices Soar (Bloomberg )

      • Portugal:

        • Portugal is set to replace Centeno as Central Bank Governor (Bloomberg )

    • Company news:

      • Notable Gainers

        • +25.0% ALSTW.FP (StreamWIDE €55.00, +11.00) -- sales

        • +16.6% ISOFOL.SS (Isofol Medical SEK1.00, +0.14) -- completes pre-IND meeting with the FDA for arfolitixorin

        • +13.6% HBC.NO (Hofseth BioCare NOK2.01,+0.24) -- shares halted; ProGo award

        • +13.5% BAR.BB (Barco €14.26, +1.70) -- H1 EPS €0.27 vs FactSet €0.20 [1 est]

        • +13.5% CHRT.LN (Cohort £17.48, +2.08) -- earnings

        • +12.3% INRN.SW (Interroll Holding CHF2,280.00, +250.00) -- upgraded to buy from neutral at UBS

        • +10.2% CRW.LN (Craneware £24.80, +2.30) -- FY Trading Update: expects 12% increase in adjusted EBITDA to over $65M; FactSet $63.2M [4 est, $62.7-63.6M]

        • +9.3% ENEA.SS (Enea AB SEK74.40, +6.30) -- earnings; buyback

        • +8.6% SEDANA.SS (Sedana Medical SEK12.44, +0.98) -- publishes results of paediatric study IsoCOMFORT (SED002) in The Lancet Respiratory Medicine

        • +6.2% BMY.LN (Bloomsbury Publishing £5.17, +0.30) -- AGM trading update: expects FY results in line with consensus expectations

        • +5.4% BERG.B.SS (Bergman & Beving SEK313.50, +16.00) -- Q1 adj EPS SEK2.05 vs FactSet SEK2.65 [4 est, SEK2.10-3.29]

        • +5.1% CEC.GR (CECONOMY €3.89, +0.19) -- prelim Q3 EBIT (€31M); guides FY adjusted ~EBIT €375M vs FactSet €366M [6 est, €359-378.1M]

        • +5.1% PGHN.SW (Partners Group Holding CHF1,114.50, +54.00) -- solid AuM development in H1 and reconfirms FY25 guidance

        • +4.9% ALMB.DC (Alm. Brand DKK18.27, +0.85) -- Q2 EPS DKK0.20 vs FactSet DKK0.26 [5 est, DKK0.20-0.30]; raises pre-tax profit guidance ex-items by DKK100M to DKK1.73-1.93B

        • +3.4% ICG.LN (Intermediate Capital Group £20.44, +0.67) -- Q1 Trading Update: AUM of $123B, fee-earning AUM of $82B, AUM not yet earning fees of $19B

        • +2.7% PRTC.LN (PureTech Health £1.37, +0.04) -- CEO steps down today

        • +2.4% MIPS.SS (MIPS SEK452.60, +10.80) -- Q2 EPS SEK1.20 vs FactSet SEK1.22 [6 est, SEK0.99-1.34]

        • +1.7% ALBPS.FP (Biophytis €0.14, -0.00) -- favorable ruling from French Court of Cassation in legal dispute with Negma Group

        • +0.8% DWL.LN (Dowlais Group Plc £0.72, +0.01) -- American Axle (AXL) shareholders approve proposed combination with Dowlais Group

        • +0.6% DGE.LN (Diageo £18.99, +0.11) -- Debra Crew has stepped down as CEO with immediate effect, by mutual agreement

      • Notable Decliners

        • -29.2% DDRIL.NO (Dolphin Drilling AS NOK0.07, -0.03) -- updates on private placement and refinancing

        • -18.5% RNO.FP (Renault €33.63, -7.62) -- prelim H1 revenue €27.60B vs FactSet €27.58B [5 est, €27.34-27.76B]; lowers FY25 guidance

        • -17.3% NIL.B.SS (Nilörngruppen SEK56.00, -11.70) -- earnings

        • -16.1% BAKKA.NO (Bakkafrost NOK395.80, -75.80) -- preliminary Q2 operational EBIT of ~ DKK 65M

        • -16.0% ITAB.SS (ITAB Shop Concept SEK19.12, -3.63) -- earnings

        • -14.9% GNRO.FP (GeNeuro €0.04, -0.01) -- liquidation of subsidiary

        • -12.9% FPE3.GR (FUCHS SE €41.16, -6.10) -- prelim H1 EBIT €209.0M vs year-ago €218.0M; lowers FY25 guidance

        • -12.9% ONTEX.BB (Ontex Group €6.41, -0.95) -- Q2 operating income €13.9M vs year-ago (€3.1M); revises FY guidance lower

        • -12.8% MCB.LN (McBride £1.32, -0.19) -- FY trading update: group anticipates FY adjusted operating profit in line with expectations

        • -11.6% RECSI.NO (REC Silicon NOK2.20, -0.29) -- issues further update on the financial situation; to call EGM during the week starting 4-Aug

        • -11.4% ASML.NA (ASML Holding €625.80, -80.30) -- Q2 EPS €5.90 vs consensus €5.24; guides Q3 and FY25

        • -9.0% SHB.A.SS (Svenska Handelsbanken SEK114.15, -11.25) -- Q2 EPS SEK2.77 vs FactSet SEK2.97

        • -7.6% ORX.SS (Orexo SEK18.72, -1.53) -- Q2 EPS (SEK1.15) including item and unclear if comparable to FactSet (SEK0.37) [1 est]; reaffirms 2025 financial outlook

        • -7.4% FIA1S.FH (Finnair €2.86, -0.23) -- Q2 EPS €0.06 vs FactSet €0.05 [6 est, €0.00-0.09]

        • -6.5% ATEA.NO (Atea NOK146.00, -10.20) -- Q2 net income NOK157M vs FactSet NOK196.5M [4 est, NOK175.1-210M]

        • -6.5% BRG.NO (Borregaard NOK194.00, -13.50) -- Q2 EPS NOK2.56 vs FactSet NOK2.59 [8 est, NOK2.07-2.81]

        • -6.2% GENL.LN (Genel Energy £0.61, -0.04) -- DNO announcement on suspension of production at Kurdistan Fields following explosions

        • -6.2% STLAM.IM (Stellantis €8.00, -0.53) -- to exit hydrogen fuel cell technology JV Symbio

          • -4.2% FRVIA.FP (Forvia €9.53, -0.41)

        • -6.1% IMPN.SW (Implenia CHF51.90, -3.40) -- holder Rudolf Maag offers 1M shares via UBS -- Bloomberg, citing terms

        • -5.4% B3.SS (B3 Consulting Group SEK56.50, -3.20) -- earnings

        • -5.1% ESNT.LN (Essentra £1.13, -0.06) -- Essentra shares move higher on renewed takeover speculation, we're told

        • -4.6% GKP.LN (Gulf Keystone Petroleum £1.63, -0.08) -- suspends production at Shaikan Field operations due to explosions at number of oil fields in vicinity

        • -4.6% OUT1V.FH (Outokumpu €3.45, -0.17) -- to underweight from equal weight at Barclays

        • -4.1% SOBI.SS (Swedish Orphan Biovitrum SEK282.20, -12.00) -- Q2 adj EPS SEK2.36 vs consensus SEK1.68; keeps FY25 outlook unchanged

        • -4.0% ASKER.SS (Asker Healthcare Group SEK101.46, -4.22) -- downgraded to hold from buy at Nordea

        • -3.6% DNO.NO (DNO ASA NOK14.12, -0.53) -- suspension of production at Kurdistan Fields following explosions

        • -3.3% NSI.NA (NSI NV €23.25, -0.80) -- H1 EPRA EPS €0.99 vs year-ago €0.91

        • -3.2% WITH.FH (WithSecure €1.02, -0.03) -- earnings

        • -3.0% NEL.NO (NEL ASA NOK2.62, -0.08) -- Q2 EPS (NOK0.07) vs FactSet (NOK0.08) [6 est, (NOK0.10)-(0.06)]

        • -2.3% FAG.SS (Fagerhult Group SEK42.30, -1.00) -- acquires smart outdoor lighting company Capelon in Sweden; terms undisclosed

        • -2.3% HYQ.GR (Hypoport €208.00, -5.00) -- Q2 operational update: Europace transaction volume for mortgages +12% y/y

        • -1.8% ELN.IM (El.En. €11.26, -0.21) -- completes sale of majority stake in Penta Laser Zhejiang Co., Ltd to Yangtze Optical Fibre and Cable (post EU close 15-Jul)

        • -1.5% SEB.A.SS (Skandinaviska Enskilda Banken SEK162.15, -2.55) -- reports Q2 EPS SEK4.08 vs consensus SEK3.80

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: Sligro Food Group (SLIGR.NA), Nedap NV (NEDAP.NA)

        • Finland: Fiskars (FSKRS.FH), Alma Media (ALMA.FH), Terveystalo (TTALO.FH), Scanfil (SCANFL.FH), Atria (ATRAV.FH), Verkkokauppa.com (VERK.FH), SSH Communications Security (SSH1V.FH),

        • France: Publicis Groupe (PUB.FP)

        • Norway: Tomra Systems (TOM.NO), TGS-NOPEC Geophysical Co. (TGS.NO), Komplett (KOMPL.NO), Hexagon Purus (HPUR.NO)

        • Southern Europe: Logista Integral (LOG.SM), SeSa (SES.IM)

        • Sweden: Investor (INVE.B.SS), Nordea Bank (NDA.SE.SS), Volvo (VOLV.B.SS), EQT (EQT.SS), Assa Abloy (ASSA.B.SS), Swedbank (SWED.A.SS), Essity (ESSITY.B.SS), Evolution (EVO.SS), Tele2 (TEL2.B.SS), Trelleborg (TREL.B.SS), AarhusKarlshamn (AAK.SS), Volvo Car (VOLCAR.B.SS), Camurus (CAMX.SS), Vitrolife (VITR.SS), Cibus Nordic Real Estate (CIBUS.SS), Cloetta (CLA.B.SS), Ratos (RATO.B.SS), Scandi Standard (SCST.SS), VBG Group (VBG.B.SS), Alligo (ALLIGO.B.SS), Bonava (BONAV.B.SS), Cint Group (CINT.SS), VNV Global (VNV.SS), KlaraBo (KLARA.B.SS), Hansa Biopharma (HNSA.SS), PowerCell Sweden (PCELL.SS), Midsona (MSON.B.SS), Prevas (PREV.B.SS), Softronic (SOF.B.SS), CTEK (CTEK.SS), Pricer (PRIC.B.SS), Embellence Group (EMBELL.SS), Viaplay Group (VPLAY.A.SS)

        • Switzerland: Novartis (NOVN.SW), ABB Limited (ABBN.SW), SFS Group (SFSN.SW), DKSH Holding (DKSH.SW)

        • UK: Ocado Group (OCDO.LN), Ilika (IKA.LN)

        • Other: Icelandair Group (ICEAIR.IR)

      • Trading Update:

        • DACHs: Renk Group (R3NK.GR)

        • France: Stef (STF.FP), Maurel et Prom (MAU.FP), Abéo (ABEO.FP), ATEME (ATEME.FP)

        • Southern Europe: Ferrovial (FER.SM) 407 ETR H1 results

        • UK: Scottish and Southern Energy (SSE.LN), Wise (WISE.LN), Diploma (DPLM.LN), QinetiQ Group (QQ.LN), Dunelm Group (DNLM.LN)

  • Data:

    • Economics:

      • Eurozone May Trade Balance €16.2B vs consensus €13.0B and prior revised €11.1B from €9.9B

      • UK Jun

        • CPI +3.6% y/y vs consensus +3.4% and prior +3.4%; +0.3% m/m vs consensus +0.2% and prior +0.2%

          • Core +3.7% y/y vs consensus +3.5% and prior +3.5%

        • RPI +4.4% y/y vs consensus +4.3% and prior +4.3%; +0.4% m/m vs consensus +0.3% and prior +0.2%

      • Italy

        • Jun CPI +1.7% y/y vs preliminary +1.7%; +0.2% m/m vs preliminary +0.2%

          • EU Harmonised: +1.8% y/y vs preliminary 1.7%; +0.2% m/m vs preliminary +0.2%

        • May Trade Balance €6.16B vs consensus €2.9B and prior revised €2.45B from €2.48B

    • Markets:

      • WTI Crude (Aug 25): ($0.83) or (1.25%) to $65.69

      • €-$ +0.0073 or +0.63% to 1.1675

      • £-$ +0.0072 or +0.54% to 1.3456

      • €-£ +0.0008 to 0.8677

      • S&P 500 (0.27%)

      • Performance year-to-date

        • FTSE 100: +9.22%

        • DAX: +20.59%

        • CAC: +4.62%

        • MIB: +16.31%

        • Stoxx 600: +6.74%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE